COTA Lands $34M to Drive Innovation in Oncology Using Real-World Data
What You Should Know: - COTA, Inc., a healthcare technology company that uses real-world data to bring clarity to cancer care, has secured $34M in funding. - Access to over one million patient data records and additional funding support enhanced real-world data and analytics services in oncology. COTA, Inc., a Boston, MA-based healthcare technology company that uses real-world data to bring clarity to cancer care, today announced it has raised $34 million in Series D funding led
Medidata, TriNetX, Datavant Partner to Accelerate Use of RWD
What You Should Know: - Today, Medidata, TriNetX, and Datavant announced a partnership to accelerate the use of real-world data (RWD) to power clinical research. - Linking RWD, which is data not collected during the specific context of a clinical trial, can help improve understanding of the long-term safety and efficacy of new therapies. Medidata, a Dassault Systèmes company, TriNetX, and Datavant announced a partnership that will accelerate the use of real-world data (RWD) to
TriNetX Acquires European Clinical Data Network InSite
TriNetX's acquisition of Belgium-based InSite Promises to Bring New Pharmaceutical-Sponsored Clinical Trials to Healthcare Organizations Throughout Europe. TriNetX, a global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE) has acquired Belgium-based Custodix NV and its InSite network. InSite network is a European-based provider of services for clinical trial design, patient feasibility, and enabling
TriNetX Lands $40M to Expand Global Health Research Network
TriNetX, a Cambridge, MA-based global health research network that optimizes clinical research and enables discoveries through the creation of real-world evidence (RWE) has raised $40 million in Series D funding. The Series D funding round was led by Merck Global Health Innovation Fund (Merck GHIF) along with new investors Mitsui & Co., Ltd., ITOCHU Technology Ventures, ITOCHU Corporation, and existing investors MPM Capital, F2 Ventures, and Deerfield Management. To date, TriNetX has raised
Carilion Clinic Joins TriNetX Network to Expand Clinical Research and Collaboration Opportunities
TriNetX, the global health research network, will announce the latest addition to its research network: Carilion Clinic, a not-for-profit healthcare organization based in Roanoke, Virginia. By joining the network, Carilion will enhance its researchers' ability to quickly execute clinical trials and collaborate with other industry TriNetX network members. Carilion, serves nearly one million residents and owns and operates seven hospitals, more than 225 outpatient practices, and Jefferson College
Cardiovascular Research Consortium to Provide Access to Real-World Heart Care Data Via TriNetX
Today TriNetX, the global health research network, announced that the Cardiovascular Research Consortium (CRC) has selected TriNetX's real-world evidence platform to provide the biopharma industry with the first-of-its-kind access to extensive cardiology-specific clinical data. The CRC is a nationwide network of community-based cardiology practices and is one of the largest searchable cardiology patient bases in the U.S, treating an upwards of 3 million patients across 30+ states. Heart disease
Can NLP Text-Mining Transform Drug Discovery & Development for Biopharma?
by Jane Reed, Head of Life Science Strategy at Linguamatics 01/31/2018 Leave a Comment
Healthcare is in the midst of a data explosion, thanks to the widespread adoption of electronic health records (EHRs), the increased sophistication of insurance claims databases, and the growth of social media. These real-world data provide critical insights into the health of patients and can be leveraged to advance pharma and biotech initiatives that improve the delivery of care.This wealth of clinical data is particularly valuable for organizations seeking to understand the real-world impact